Impact of IL-10 on diaphragmatic cytokine expression and contractility during Pseudomonas infection

American Journal of Respiratory Cell and Molecular Biology

Volumn 36, Issue 4, 2007, Pages 504-512

  Divangahi, Maziar ^b   Demoule, Alexandre ^b   Danialou, Gawiyou ^b   Yahiaoui, Linda ^b   Bao, Weisheng ^b   Xing, Zhou ^b   Petrof, Basil J ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

^b NONE

Author keywords

Cytokines; Diaphragm; Gene transfer; Interleukin 10; Sepsis

Indexed keywords

ADENOVIRUS VECTOR; GENE PRODUCT; INTERLEUKIN 10;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIAPHRAGM MOVEMENT; DIAPHRAGM MUSCLE; GENE; GENE EXPRESSION REGULATION; HUMAN; IL 10 GENE; IL 18 GENE; IL 1ALPHA GENE; IL 1BETA GENE; IL 6 GENE; LUNG INFECTION; MOUSE; MUSCLE CONTRACTILITY; MUSCLE FIBER CULTURE; NONHUMAN; PNEUMONIA; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PSEUDOMONAS AERUGINOSA; TNF ALPHA GENE; TRANSGENE; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; CELLS, CULTURED; CYTOKINES; DIAPHRAGM; INFLAMMATION; INTERLEUKIN-10; LUNG DISEASES; MICE; MICE, INBRED C57BL; MUSCLE CONTRACTION; PSEUDOMONAS INFECTIONS; RECEPTORS, INTERLEUKIN-10; TRANSDUCTION, GENETIC; UP-REGULATION;

BACTERIA (MICROORGANISMS); MURINAE; MUS; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 34247192014     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2006-0038OC     Document Type: Article

References (55)

1. Hussain SNA, Simkus G, Roussos C. Respiratory muscle fatigue: a cause of ventilatory muscle failure in septic shock. J Appl Physiol 1985;58:2033-2040.
2. Bone RC, Sprung CL, Sibbald WJ. Definitions for sepsis and organ failure. Crit Care Med 1992;20:724-726.
3. Montgomery A, Stager M, Carrico C, Hudson L. Causes of mortality in patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1985;132:485-489.
4. Divangahi M, Matecki S, Dudley RW, Tuck SA, Bao W, Radzioch D, Comtois AS, Petrof BJ. Preferential diaphragmatic weakness during sustained Pseudomonas aeruginosa lung infection. Am J Respir Crit Care Med 2004;169:679-686.
5. Shindoh C, DiMarco A, Nethery D. Effect of PEG-superoxide dismutase on the diaphragmatic response to endotoxin. Am Rev Respir Dis 1992;145:1350-1354.
6. Boczkowski J, Lanone S, Ungureanu-Longrois D, Danialou G, Fournier T, Aubier M. Induction of diaphragmatic nitric oxide synthase after endotoxin administration in rats. J Clin Invest 1996;98:1550-1559.
7. Shindoh C, Hida W, Ohkawara Y, Yamauchi K, Ohno I, Takishima T, Shirato K. TNF-α mRNA expression in diaphragm muscle after endotoxin administration. Am J Respir Crit Care Med 1995;152:1690-1696.
8. Wilcox P, Milliken C, Bressler B. High-dose tumor necrosis factor α produces an impairment of hamster diaphragm contractility. Am J Respir Crit Care Med 1996;153:1611-1615.
9. Wilcox P, Osborne S, Bressler B. Monocyte inflammatory mediators impair in vitro hamster diaphragm contractility. Am Rev Respir Dis 1992;146:462-466.
10. Janssen SP, Gayan-Ramirez G, Van den BA, Herijgers P, Maes K, Verbeken E, Decramer M. Interleukin-6 causes myocardial failure and skeletal muscle atrophy in rats. Circulation 2005;111:996-1005.
11. Li Y-P. Schwartz RJ, Waddell ID, Holloway BR, Reid MB. Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-kB activation in response to tumor necrosis factor α. FASEB J 1998;12:871-880.
12. Cooney RN, Maish GO III, Gilpin T, Shumate ML, Lang CH, Vary TC. Mechanism of IL-1 induced inhibition of protein synthesis in skeletal muscle. Shock 1999;11:235-241.
13. de Alvaro C, Teruel T, Hernandez R, Lorenzo M. Tumor necrosis factor alpha produces insulin resistance in skeletal muscle by activation of inhibitor kappaB kinase in a p38 MAPK-dependent manner. J Biol Chem 2004;279:17070-17078.
14. Tracey KJ, Lowry SF, Beutler B, Cerami A, Albert JD, Shires GT. Cachectin/tumor necrosis factor mediates changes of skeletal muscle plasma membrane potential. J Exp Med 1986;164:1368-1373.
15. Reid MB, Lannergren J, Westerblad H. Respiratory and limb muscle weakness induced by tumor necrosis factor alpha: involvement of muscle myofilaments. Am J Respir Crit Care Med 2002;166:479-484.
16. Gogos CA, Drosou E, Bassaris HP, Skoutelis A. Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J Infect Dis 2000;181:176-180.
17. Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989;170:2081-2095.
18. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991;147:3815-3822.
19. Bogdan C, Vodovotz Y, Nathan C. Macrophage deactivation by interleukin 10. J Exp Med 1991;174:1549-1555.
20. de Waal Malefyt R, Haanen J, Spits H, Roncarolo MG, te Velde A, Figdor C, Johnson K, Kastelein R, Yssel H, de Vries JE. Interleukin 10 (1L-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 1991;174:915-924.
21. Willems F, Marchant A, Delville JP, Gerard C, Delvaux A, Velu T, de Boer M, Goldman M. Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes. Eur J Immunol 1994;24:1007-1009.
22. Xing Z, Ohkawara Y, Jordana M, Graham FL, Gauldie J. Adenoviral vector-mediated interleukin-10 expression in vivo: intramuscular gene transfer inhibits cytokine responses in endotoxemia. Gene Ther 1997;4:140-149.
23. Howard M, Muchamuel T, Andrade S, Menon S. Interleukin 10 protects mice from lethal endotoxemia. J Exp Med 1993;177:1205-1208.
24. Starke JR, Edwards MS, Langston C, Baker CJ. A mouse model of chronic pulmonary infection with Pseudomonas aeruginosa and Pseudomonas cepacia. Pediatr Res 1987;22:698-702.
25. Gosselin D, Stevenson MM, Cowley EA, Griesenbach U, Eidelman DH, Boulé M, Tam M-F, Kent G, Skamene E, Tsui L-C, et al. Impaired ability of Cftr knockout mice to control lung infection with Pseudomonas aeruginosa. Am J Respir Crit Care Med 1998;157:1253-1262.
26. Demoule A, Divangahi M, Danialou G, Gvozdic D, Larkin G, Bao W, Petrof BJ. Expression and regulation of CC class chemokines in the dystrophic (mdx) diaphragm. Am J Respir Cell Mol Biol 2005;33:178-185.
27. Yang L, Lochmüller H, Luo J, Massie B, Nalbantoglu J, Karpati G, Petrof BJ. Adenovirus-mediated dystrophin minigene transfer improves muscle strength in adult dystrophic (mdx) mice. Gene Ther 1998;5:369-379.
28. Maltais F, LeBlanc P, Jobin J, Casaburi R. Peripheral muscle dysfunction in chronic obstructive pulmonary disease. Clin Chest Med 2000;21:665-677.
29. Raeburn CD, Dinarello CA, Zimmerman MA, Calkins CM, Pomerantz BJ, McIntyre RC Jr, Harken AH, Meng X. Neutralization of IL-18 attenuates lipopolysaccharide-induced myocardial dysfunction. Am J Physiol Heart Circ Physiol 2002;283:H650-H657.
30. Lin MC, Ebihara S, el-Dwairi Q, Hussain SNA, Yang L, Gottfried SB, Comtois A, Petrof BJ. Diaphragm sarcolemmal injury is induced by sepsis and alleviated by nitric oxide synthase inhibition. Am J Respir Crit Care Med 1998;158:1656-1663.
31. Coopersmith CM, Amiot DM, Stromberg PE, Dunne WM, Davis CG, Osborne DF, Husain KD, Turnbull IR, Karl IE, Hotchkiss RS, et al. Antibiotics improve survival and alter the inflammatory profile in a marine model of sepsis from Pseudomonas aeruginosa pneumonia. Shock 2003;19:408-414.
32. Demoule A, Divangahi M, Yahiaoui L, Danialou G, Gvozdic D, Labbe K, Bao W, Petrof BJ. Endotoxin triggers NF-kB-dependent upregulation of multiple pro-inflammatory genes in the diaphragm. Am J Respir Crit Care Med 2006;174:646-653.
33. Hussain SN, Giaid A, El Dawiri Q, Sakkal D, Hattori R, Guo Y. Expression of nitric oxide synthases and GTP cyclohydrolase 1 in the ventilatory and limb muscles during endotoxemia. Am J Respir Cell Mol Biol 1997;17:173-180.
34. Supinski G, Nethery D, Stofan D, DiMarco A. Comparison of the effects of endotoxin on limb, respiratory, and cardiac muscles. J Appl Physiol 1996;81:1370-1378.
35. van Heeckeren AM, Tscheikuna J, Walenga RW, Konstan MW, Davis PB, Erokwu B, Haxhiu MA, Ferkol TW. Effect of Pseudomonas infection on weight loss, lung mechanics, and cytokines in mice. Am J Respir Crit Care Med 2000;161:271-279.
36. Porter JD, Merriam AP, Leahy P, Gong B, Feuerman J, Cheng G, Khanna S. Temporal gene expression profiling of dystrophin-deficient (mdx) mouse diaphragm identifies conserved and muscle group-specific mechanisms in the pathogenesis of muscular dystrophy. Hum Mol Genet 2004;13:257-269.
37. Vassilakopoulos T, Divangahi M, Rallis G, Kishta O, Petrof B, Comtois A, Hussain SN. Differential cytokine gene expression in the diaphragm in response to strenuous resistive breathing. Am J Respir Crit Care Med 2004;170:154-161.
38. Li X, Moody MR, Engel D, Walker S, Clubb FJ Jr, Sivasubramanian N, Mann DL, Reid MB. Cardiac-specific overexpression of tumor necrosis factor-alpha causes oxidative stress and contractile dysfunction in mouse diaphragm. Circulation 2000;102:1690-1696.
39. Frost RA, Lang CH, Gelato MC. Transient exposure of human myoblasts to tumor necrosis factor-alpha inhibits serum and insulin-like growth factor-1 stimulated protein synthesis. Endocrinology 1997;138:4153-4159.
40. Li YP, Chen Y, John J, Moylan J, Jin B, Mann DL, Reid MB. TNF-alpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle. FASEB J 2005;19:362-370.
41. Langen RC, Van Der Velden JL, Schols AM, Kelders MC, Wouters EF, Janssen-Heininger YM. Tumor necrosis factor-alpha inhibits myogenic differentiation through MyoD protein destabilisation. FASEB J 2004;18:227-237.
42. Woldbaek PR, Tonnessen T, Henriksen UL, Florholmen G, Lunde PK, Lyberg T, Christensen G. Increased cardiac IL-18 mRNA. pro-IL-18 and plasma IL-18 after myocardial infarction in the mouse; a potential role in cardiac dysfunction. Cardiovasc Res 2003;59:122-131.
43. Tsujinaka T, Kishibuchi M, Yano M, Morimoto T, Ebisui C, Fujita J, Ogawa A, Shiozaki H, Kominami E, Monden M. Involvement of interleukin-6 in activation of lysosomal cathepsin and atrophy of muscle fibers induced by intramuscular injection of turpentine oil in mice. J Biochem (Tokyo) 1997;122:595-600.
44. Acharyya S, Ladner KJ, Nelsen LL, Damrauer J, Reiser PJ, Swoap S, Guttridge DC. Cancer cachexia is regulated by selective targeting of skeletal muscle gene products. J Clin Invest 2004;114:370-378.
45. Cai D, Frantz JD, Tawa NE Jr, Melendez PA, Oh BC, Lidov HG, Hasselgren PO, Frontera WR, Lee J, Glass DJ, et al. IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell 2004;119:285-298.
46. Frost RA, Nystrom GJ, Lang CH. Lipopolysaccharide regulates proinflammatory cytokine expression in mouse myoblasts and skeletal muscle. Am J Physiol Regul Integr Comp Physiol 2002;283:R698-R709.
47. Marino M, Scuderi F, Mannella F, Bartoccioni E. TGF-beta 1 and IL-10 modulate IL-1 beta-induced membrane and soluble ICAM-1 in human myoblasts. J Neuroimmunol 2003:134:151-157.
48. Sawa T, Corry DB, Cropper MA, Ohara M, Kurahashi K, Wiener-Kronish JP. IL-10 improves lung injury and survival in Pseudomonas aeruginosa pneumonia. J Immunol 1997;159:2858-2866.
49. Kurahashi K, Kajikawa O, Sawa T, Ohara M, Gropper MA, Frank DW, Martin TR, Wiener-Kronish JP. Pathogenesis of septic shock in Pseudomonas aeruginosa pneumonia. J Clin Invest 1999;104:743-750.
50. Marshall JC. Clinical trials of mediator-directed therapy in sepsis: what have we learned? Intensive Care Med 2000;26:S75-S83.
51. Ledeboer A, Binnekade R, Breve JJ, Bol JG, Tilders FJ, Van Dam AM. Site-specific modulation of LPS-induced fever and interleukin-1 beta expression in rats by interleukin-10. Am J Physiol Regul Integr Comp Physiol 2002;282:R1762-R1772.
52. Chmiel JF, Konstan MW, Knesebeck JE, Hilliard JB, Bonfield TL, Dawson DV, Berger M. IL-10 attenuates excessive inflammation in chronic Pseudomonas infection in mice. Am J Respir Crit Care Med 1999;160:2040-2047.
53. Taneda A, Shindoh C, Ohuchi Y, Shirato K. Protective effects of interleukin-10 on diaphragm muscle in a septic animal model. Tohoku J Exp Med 1998;185:45-54.
54. Oberholzer A, Oberholzer C, Moldawer LL. Interleukin-10: a complex role in the pathogenesis of sepsis syndromes and its potential as an anti-inflammatory drug. Crit Care Med 2002;30:S58-S63.
55. Lauw FN, Pajkrt D, Hack CE, Kurimoto M, van Deventer SJ, van der Poll T. Proinflammatory effects of IL-10 during human endotoxemia. J Immunol 2000;165:2783-2789.